4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000024
Director disposed of 13,550,136 shares (other)
- Director acquired 15,946,502 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
NARINE JEENARINE · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-03-21 | Conversion : show line 1 in the form | +15,946,502 | 29,435,091 | I | ||
| 2013-03-25 | Other disposition : show line 2 in the form | −13,550,136 | $0.04 | $500,000 | 15,884,955 | I |
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-03-21 | Conversion : show line 3 in the form Series E Convertible Preferred Stock | −387.5 | $1,000.00 | $387,500 | 1,800 | I |
| 2013-03-25 | Other disposition : show line 4 in the form Warrants | −6,666,667 | 2,436,665 | I |
Loading xslF345X03/primary_doc.xml…